PDCO - Patterson Companies, Inc.
NASDAQ
->
Healthcare
->
Medical Distribution
Saint Paul,
United States
Type: Equity
PDCO price evolution
PDCO
| (in millions $) | 27 Aug 2024 | 30 Jul 2024 | 27 Feb 2024 | 28 Nov 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $148.08 | $114.46 | $124 | |
| Short term investments | ||||
| Net receivables | $442.34 | $547.29 | $484.53 | $490.43 |
| Inventory | $849.5 | $782.9 | $902.73 | $858.03 |
| Total current assets | $1762.11 | $1778.76 | $1832.56 | $1790.68 |
| Long term investments | $167.39 | $166.32 | $164.46 | |
| Property, plant & equipment | $350.62 | $351.38 | $334.52 | $320.51 |
| Goodwill & intangible assets | $340.17 | $349.59 | $359.59 | |
| Total noncurrent assets | $1112.65 | $1117.97 | $1107.39 | |
| Total investments | $167.39 | $166.32 | $164.46 | |
| Total assets | $2874.76 | $2896.73 | $2939.95 | $2889.69 |
| Current liabilities | ||||
| Accounts payable | $656.98 | $745.38 | $683.3 | $688.69 |
| Deferred revenue | ||||
| Short long term debt | $477.52 | $341.56 | $366.26 | |
| Total current liabilities | $1357.52 | $1332.55 | $1283.71 | $1148.54 |
| Long term debt | $327.15 | $328.91 | $448.22 | $449.97 |
| Total noncurrent liabilities | $564.74 | $562.45 | $684.07 | |
| Total debt | $898.93 | $762.94 | $894.98 | |
| Total liabilities | $1922.77 | $1895.59 | $1968.47 | $1835.39 |
| Shareholders' equity | ||||
| Retained earnings | $772 | $831.48 | $802.88 | $902.83 |
| Other shareholder equity | -$86.47 | -$89.92 | -$86.16 | -$98.96 |
| Total shareholder equity | $951.99 | $1001.14 | $971.48 | |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $114.46 | $159.67 | $142.01 | $143.24 |
| Short term investments | ||||
| Net receivables | $677.16 | $599.1 | $585.97 | $673.21 |
| Inventory | $782.9 | $795.07 | $785.6 | $736.78 |
| Total current assets | $1778.76 | $1783.14 | $1679.02 | $1615.93 |
| Long term investments | $166.32 | $160.02 | $139.18 | |
| Property, plant & equipment | $351.38 | $305.24 | $283.86 | $296.65 |
| Goodwill & intangible assets | $349.59 | $388.29 | $393.24 | $419.58 |
| Total noncurrent assets | $1117.97 | $1096.01 | $1062.61 | $1135.58 |
| Total investments | $166.32 | $160.02 | $139.18 | |
| Total assets | $2896.73 | $2879.15 | $2741.63 | $2751.51 |
| Current liabilities | ||||
| Accounts payable | $745.38 | $724.99 | $681.32 | $609.26 |
| Deferred revenue | ||||
| Short long term debt | $341.56 | $109.39 | $58.35 | $186 |
| Total current liabilities | $1332.55 | $1085.33 | $1015.67 | $1089.67 |
| Long term debt | $421.38 | $518.61 | $531.89 | $535.86 |
| Total noncurrent liabilities | $562.45 | $675.28 | $683.33 | $697.17 |
| Total debt | $762.94 | $628 | $590.23 | $721.87 |
| Total liabilities | $1895 | $1760.61 | $1698.99 | $1786.84 |
| Shareholders' equity | ||||
| Retained earnings | $831.48 | $972.13 | $921.7 | $855.74 |
| Other shareholder equity | -$89.92 | -$89.26 | -$81.52 | -$62.59 |
| Total shareholder equity | $1001.14 | $1117.54 | $1041.68 | $963.22 |
| (in millions $) | 30 Jul 2025 | 1 May 2025 | 27 Aug 2024 | 30 Jul 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1541.74 | |||
| Cost of revenue | ||||
| Gross Profit | $312.61 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $283.24 | |||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $4.22 | |||
| Interest expense | -$11.51 | |||
| Net income | ||||
| Net income | $13.71 | |||
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6568.27 | $6471.47 | $6499.4 | $5912.07 |
| Cost of revenue | $5188.03 | $5098.53 | $5210.32 | $4708.94 |
| Gross Profit | $1380.24 | $1372.94 | $1289.09 | $1203.13 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1127.32 | $1096.97 | $1132.09 | $992.52 |
| Total operating expenses | $1127.32 | $1096.97 | $1132.09 | $992.52 |
| Operating income | $252.92 | $275.97 | $157 | $210.61 |
| Income from continuing operations | ||||
| EBIT | $288.38 | $304.76 | $288.04 | $225.09 |
| Income tax expense | $57.53 | $63.56 | $64.54 | $44.82 |
| Interest expense | $44.91 | $33.64 | $20.29 | $24.28 |
| Net income | ||||
| Net income | $185.93 | $207.56 | $203.21 | $155.98 |
| Income (for common shares) | $185.93 | $207.56 | $203.21 | $155.98 |
| (in millions $) | 27 Aug 2024 | 27 May 2024 | 27 Feb 2024 | 28 Nov 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $258.33 | $959.54 | $718.01 | $454.86 |
| Financing activities | ||||
| Dividends paid | -$23.31 | -$98.33 | -$75.02 | -$50.3 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $58.79 | -$215.91 | -$34.09 | -$13.16 |
| Effect of exchange rate | $1.47 | $0.53 | $0.25 | -$2.17 |
| Change in cash and equivalents | $33.62 | -$45.21 | -$35.67 | -$45.79 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $185.93 | $207.56 | $203.21 | $155.98 |
| Operating activities | ||||
| Depreciation | $88.16 | $83.7 | $81.99 | $78.9 |
| Business acquisitions & disposals | $1027.17 | $965.63 | $1193.7 | $833.96 |
| Stock-based compensation | $17.87 | $15.54 | $23.8 | $30.49 |
| Total cash flows from operations | -$789.38 | -$754.85 | -$980.99 | -$730.52 |
| Investing activities | ||||
| Capital expenditures | -$67.63 | -$64.22 | -$38.31 | -$25.79 |
| Investments | -$15 | $75.94 | ||
| Total cash flows from investing | $959.54 | $901.57 | $1239.03 | $810.66 |
| Financing activities | ||||
| Dividends paid | -$98.33 | -$101.35 | -$101.11 | -$75.18 |
| Sale and purchase of stock | -$229.51 | -$55.49 | -$35 | |
| Net borrowings | $105 | $14.5 | -$124.75 | $53 |
| Total cash flows from financing | -$215.91 | -$126.48 | -$253.23 | -$22.64 |
| Effect of exchange rate | $0.53 | -$2.58 | -$6.03 | $7.8 |
| Change in cash and equivalents | -$45.21 | $17.66 | -$1.23 | $65.3 |
News
Fundamentals
| Market cap | $2.74B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 88.15M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.89 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.30 |
| Quick ratio | 0.67 |